# First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)

> **NCT00392054** · PHASE3 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 127 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Pulmonary Vein Isolation performed by Catheter Ablation
- **DRUG:** Conventional Antiarrhythmic Drug Therapy

## Key facts

- **NCT ID:** NCT00392054
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2020-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392054, "First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00392054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*